Coreg CR Opens New Opportunity In Hypertension, GSK’s Stout Says
The once-daily formulation of carvedilol will make it a more attractive option for hypertension than the previous Coreg.
The once-daily formulation of carvedilol will make it a more attractive option for hypertension than the previous Coreg.